Vilaichone Ratha-korn, Ratanachu-Ek Thawee, Gamnarai Pornpen, Chaithongrat Supakarn, Uchida Tomahisa, Yamaoka Yoshio, Mahachai Varocha
Gastroenterology Unit, Department of Medicine, Thammasat University Hospital, Khlong Luang, Pathumthani, Thailand; Department of Surgery, Rajavithi Hospital, Bangkok, Thailand; Department of Biochemistry, Thammasat University Hospital, Khlong Luang, Pathumthani, Thailand; Division of Gastroenterology, Department of Medicine, Chulalongkorn University Hospital, Bangkok, Thailand; Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan; Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Oita, Japan; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; Gastrointestinal & Liver Center, Bangkok Hospital Medical Center (BMC), Bangkok, Thailand; National Gastric Cancer and Helicobacter pylori Research Center, Bangkok, Thailand
Gastroenterology Unit, Department of Medicine, Thammasat University Hospital, Khlong Luang, Pathumthani, Thailand; Department of Surgery, Rajavithi Hospital, Bangkok, Thailand; Department of Biochemistry, Thammasat University Hospital, Khlong Luang, Pathumthani, Thailand; Division of Gastroenterology, Department of Medicine, Chulalongkorn University Hospital, Bangkok, Thailand; Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan; Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Oita, Japan; Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas; Gastrointestinal & Liver Center, Bangkok Hospital Medical Center (BMC), Bangkok, Thailand; National Gastric Cancer and Helicobacter pylori Research Center, Bangkok, Thailand.
Am J Trop Med Hyg. 2016 Apr;94(4):717-20. doi: 10.4269/ajtmh.15-0449. Epub 2016 Feb 15.
This study aimed to survey the prevalence, patterns of antibiotic resistance, and clinical factors associated with antibiotic resistance in Helicobacter pylori among the Karen and Hmong mountain people of Thailand. We recruited dyspeptic patients in the Maesod district, Tak Province, Thailand. All subjects underwent upper gastrointestinal endoscopy, and three antral gastric biopsies were obtained for rapid urease tests and culture. An epsilometer was used to determine the minimum inhibitory concentrations of amoxicillin (AMX), clarithromycin (CLR), metronidazole (MNZ), levofloxacin (LVX), ciprofloxacin (CIP), and tetracycline (TET). A total of 291 subjects were enrolled; 149 (51.2%) were infected with H. pylori. Helicobacter pylori infection was present in 47.1% of Thai, 51.7% of Karen, and 58.7% of Hmong subjects. Antibiotic resistance was present in 75.8% including AMX (0.8%), TET (0%), CLR (5.6%), MNZ (71.8%), CIP (19.4%), LVX (19.4%), and multidrug resistance in 21.8%. Karen subjects had the highest prevalence of MNZ resistance (84.6%), and Hmong subjects had the highest prevalence of fluoroquinolone (27.3%) and multidrug (34.1%) resistance. MNZ plus fluoroquinolone (14.5%) was the most common multidrug resistance. There was no association between clinical factors and antibiotic resistance. MNZ resistance was prevalent, whereas fluoroquinolone- and multidrug-resistant H. pylori infections are important problems in mountain people of Thailand.
本研究旨在调查泰国克伦族和苗族山地人群幽门螺杆菌的感染率、抗生素耐药模式以及与抗生素耐药相关的临床因素。我们在泰国北碧府湄索地区招募了消化不良患者。所有受试者均接受了上消化道内镜检查,并获取了三块胃窦部胃活检组织进行快速尿素酶试验和培养。使用药敏测试仪测定阿莫西林(AMX)、克拉霉素(CLR)、甲硝唑(MNZ)、左氧氟沙星(LVX)、环丙沙星(CIP)和四环素(TET)的最低抑菌浓度。总共招募了291名受试者;149名(51.2%)感染了幽门螺杆菌。泰国受试者中幽门螺杆菌感染率为47.1%,克伦族为51.7%,苗族为58.7%。抗生素耐药率为75.8%,其中AMX耐药率为0.8%,TET耐药率为0%,CLR耐药率为5.6%,MNZ耐药率为71.8%,CIP耐药率为19.4%,LVX耐药率为19.4%,多重耐药率为21.8%。克伦族受试者中MNZ耐药率最高(84.6%),苗族受试者中氟喹诺酮耐药率(27.3%)和多重耐药率(34.1%)最高。MNZ加氟喹诺酮(14.5%)是最常见的多重耐药类型。临床因素与抗生素耐药之间无关联。MNZ耐药普遍存在,而氟喹诺酮和多重耐药的幽门螺杆菌感染是泰国山地人群中的重要问题。